Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2024 Q3 2023 Q1 2023 Q3 2022 Q1 2022 Q3 2021 Q1 2021
Period Ending Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
Net Income
-116.84M 16.92M -370.65M 484.51M 3.36B 5.11B 172.7M
Depreciation & Amortization
60.6M 84.15M 78.84M 77.76M 68.84M 16.61M 1.26M
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a 751K
Other Working Capital
123.02M -19.93M -319.18M -995.13M -468.29M 1.25B 355.85M
Other Non-Cash Items
-184.1M 39.43M -930.01M 1.25B 2.34B 4.23B 6.47M
Deferred Income Tax
108.45M -32.12M -67.17M -15.84M 335.99M -70.89M -6.28M
Change in Working Capital
277.9M 5K 639.63M -1.72B -85.36M 545.98M 306.19M
Operating Cash Flow
146.01M -39.99M 151.77M -808.17M 6.27B 9.09B 481.1M
Capital Expenditures
-52.75M -92.94M -150M -289.06M -307.09M -443.88M -57.87M
Cash Acquisitions
2K 37K 5K 603K 120K 52K n/a
Purchase of Investments
-1.7B -6.65B 3.42B -15.19B -4.46B -4.38B -125.89M
Sales Maturities Of Investments
1.56B 4.01B -5.56B 11.89B 5.02B 1.55B 31.61M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -163K
Investing Cash Flow
-195.19M -2.73B -2.29B -3.58B 251.31M -3.27B -152.15M
Debt Repayment
n/a n/a n/a n/a n/a n/a -5.42M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a -1.88B n/a n/a
Other Financial Acitivies
-293.23M 217.16M -253.1M 11.7M 9.21M -30M 545.06M
Financial Cash Flow
-293.23M 217.16M -253.1M 11.7M -1.87B -30M 541.64M
Net Cash Flow
-371.46M -2.64B -2.58B -4.75B 4.76B 6.7B 896.49M
Free Cash Flow
93.26M -132.93M 1.78M -1.1B 5.96B 8.64B 423.23M